Before mediation, the pathological diagnosis report confirmed non-Hodgkin’s lymphoma in the left kidney. After 5 months of chemotherapy combined with CHA for injection, follow-up examinations showed no recurrence. The level of β2-microglobulin (β2-MB), a tumor marker, decreased to normal during the two and a half years of medication. During the treatment, CHA for injection was used in combination with chemotherapy for long-term disease control. The treatment demonstrated good safety and significantly improved the toxic side effects of chemotherapy.